Evidence map›Paper›PMID 42099309›Full record

ArticleCureus2026

Severe Necrotizing Pneumonia as an Unusual Initial Manifestation of Neurofibromatosis Type 1: A Case Presentation.

Panagiota Anyfanti, Eleni Marnoutsidou, Afroditi Boutou, Aikaterini Gakidi, Nikolaos Kakaletsis, Theodoros Michailidis, Christina Nousiou, Charalambia Savva, Maria Xanthopoulou, Panagiota Kakotrichi and 5 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Panagiota AnyfantiThird Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Eleni MarnoutsidouSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Afroditi BoutouDepartment of Respiratory Medicine, Hippokration Hospital, Thessaloniki, GRC.
Aikaterini GakidiDepartment of Respiratory Medicine, Hippokration Hospital, Thessaloniki, GRC.
Nikolaos KakaletsisSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Theodoros MichailidisSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Christina NousiouSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Charalambia SavvaSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Maria XanthopoulouSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Panagiota KakotrichiSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Eleni FaniadouDepartment of Respiratory Medicine, Hippokration Hospital, Thessaloniki, GRC.
Giannis AvgerinosSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Konstantinos DimitrakopoulosSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Apostolos TsapasSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Eleni BekiariSecond Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease, is a relatively common inherited neurogenetic disorder that predisposes individuals to various benign and malignant tumors, primarily in the nervous system. Diagnosis depends on clinical manifestations; however, the clinical presentation of NF1 is highly variable, and complications of NF1 may show great heterogeneity. In this manuscript, we report the case of a 45-year-old male patient who presented with frequent episodes of fever (up to 39°C) and productive cough initially non-responsive to standard-of-care medical treatment. The chest computerized tomography (CT) findings of bullous lung disease, along with skin abnormalities (multiple café-au-lait macules and a plexiform neurofibroma) and iris Lisch nodules, raised the suspicion of undiagnosed NF1. Diagnosis of NF1 was established based on clinical criteria. This case underscores the heterogeneity that may characterize NF1 and demonstrates the diverse and unpredictable nature of the disease. Lung disease may complicate NF1, even as an early yet severe clinical presentation in a previously undiagnosed individual.

Indexed as

lung diseaselung emphysemanecrotizing pneumonianeurofibromatosis type 1 (nf-1)neurofibromatosis type 1 (nf1)von recklinghausen disease

Identifiers

PMID42099309
PMCPMC13147303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.